neuro-oncology in ayas joint efforts are worthwhile…… · medullo et pnet gliomes tgm...
TRANSCRIPT
![Page 1: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/1.jpg)
Neuro-oncology in AYAsJoint efforts are worthwhile……
Didier FRAPPAZ
Centre Léon Bérard, and IHOP Lyon, France
![Page 2: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/2.jpg)
PLAN
• Epidemiology
• The patients
• The tumors
• Toxicity
• Compliance
• Strategies
• Multidisciplinary meetings…….
![Page 3: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/3.jpg)
EPIDEMIOLOGY
![Page 4: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/4.jpg)
From: American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012Neuro Oncol. 2015;18(suppl_1):i1-i50. doi:10.1093/neuonc/nov297
Neuro Oncol | © The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail:
INCIDENCE/100,000
![Page 5: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/5.jpg)
LAUSANNE-ANOCEF-
16.05.2014
EPIDEMIOLOGY
US cancer incidence from Surveillance, Epidemiology, and End Results
(SEER), 1975 to 1998, by CNS tumor type.Kieran M W et al. JCO 2010
8 %
6 %
19 %
64 %
![Page 6: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/6.jpg)
THE PATIENTS
![Page 7: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/7.jpg)
Misleading symptomsPineal Suprasellar Bifocal
11 pts 12 pts 17 pts
(10 G) (8 F) (12 G)
DUREE DES SYMTOMES 4 mths 24 mths 36 mths
Raised intracranial Pressure 100 % 46 % 39 %
Convulsions 9 % 8 % 5 %
ENDOCRINO
• Db Insipididus 9 % 62 % 100 %
• Growth delay 0 % 38 % 50 %
• precocious puberty 0 0 17 %
VISUAL
• Vision (diplopia, VF, VA) 55 % 54 % 22 %
• Parinaud 36 0 5
HYPOTHALAMIC Synd
• Frontal Synd 0 31 % 11 %
• Anorexia 0 38 % 28 %
• Memory 9 % 31 % 28 %
HARDENBERG IJROBP 1997 39:419-26
![Page 8: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/8.jpg)
Gogtay PNAS 2004
Evolution of Gray matter
![Page 9: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/9.jpg)
Hormonal changes
Seric hormonal levels during infancy to adulthood (Ua= arbitrary units)
BOYS GIRLS
![Page 10: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/10.jpg)
Coincidence???…
![Page 11: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/11.jpg)
THE TUMORS
![Page 12: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/12.jpg)
Vadgaonkar CNS 2018
![Page 13: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/13.jpg)
Type oftumour
![Page 14: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/14.jpg)
Zhang et al., Nat Gen 2013
Médullo
KW. Pajtler, Cancer Cell 2015
EPendymomas
Pediatric brain tumors ≠ adult tumors
![Page 15: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/15.jpg)
MEDULLOBLASTOMA
![Page 16: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/16.jpg)
WHAT IS KNOWN?
Epidemiology
Biology
Optimal treatment
Long term side effects
+
+
+
+
+
+/-
?
?
Children Adults
![Page 17: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/17.jpg)
Epidemiology
Children Adults
% of brain tumors 20% 1%0.5/106 adults
% Posterior fossa
Tumors40% 6%
![Page 18: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/18.jpg)
WHO 2007 classification
Extensive Desmoplastic/ Classic Anaplastic, Large cell nodularity, nodular Anaplastic
Aggressivity
INFANTS CHILDREN ADULTS
![Page 19: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/19.jpg)
10q-
TAYLOR 2012
![Page 20: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/20.jpg)
4
3
![Page 21: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/21.jpg)
SHIH JCO 2014Intra nuclear beta cathenin +
![Page 22: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/22.jpg)
![Page 23: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/23.jpg)
The tools are similar
![Page 24: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/24.jpg)
Surgery
Increased Cranial Pressure
=> Shunt
![Page 25: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/25.jpg)
MRI Brain and spine
SURGERY
Post op MRI 24 – 72 h
Lumbar CSF (cytospin) day 10-15
RESIDUE > 1,5 cm²And/or
CSF and/or spine +
High risk
RESIDUE < 1,5 cm²and
CSF and SPINE -
Standard risk*CCG 921 : Zeltzer (JCO 1999, 832)
Defining Clinical risk factors
![Page 26: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/26.jpg)
36 Gy
54 Gy
36 Gy
Standard = Cranio-Spinal Irradiation
A
BC
D
EF
G
H
I
![Page 27: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/27.jpg)
IQ loss due to supra tentorial RT
>7
Year
<7
Year
Mulhern J Clin Oncol 2OO5, 23:5511-5519.
CSI 23 Gy CSI 36-39 Gy
(- 0.42
/year)
(- 2.41
/year,
P .05
(- 1.56
/year)
(- 3.71
/year,
P .01
![Page 28: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/28.jpg)
Chemotherapy
![Page 29: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/29.jpg)
Clinical Experience
Standard RiskChildren
![Page 30: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/30.jpg)
PNET 4
Surgery Randomisation
start RT < J 40
Chemo
CCNU, Cisplatin,
Vincristine
8 Cycles
HF RT1.0 Gy x 2
36/60/68/36 Gy
+ Vcr
St RT
1.8 Gy x 1
23.4/54/23.4 Gy
+ Vcr
![Page 31: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/31.jpg)
PNET 4
n Deaths
340 47
67 events: 66 relapses 1 death CCR
First relapse + 2 months Latest relapse at + 5.5 year
7 Year EFS 0.79± 0.04 (HFRT)7 Year EFS 0.76± 0.04 (Standard RT)
p=0.82
7 Year OS 0.82±0.03
![Page 32: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/32.jpg)
NEXT STEPLow
risk
Standard
risk
High
risk
Large Cell/
Anapastic - - +
Residue/
Metastasis< 1.5 cm2 < 1.5 cm2 > 1.5 cm2
MYC - - +
β-catenin (WNT) + - +/-
StrategyDecrease
treatment
(except if >16)
Standard
treatmentIncrease
treatment
![Page 33: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/33.jpg)
Clinical Experience
Standard riskAdults
![Page 34: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/34.jpg)
Bologna 1989 to 2009 95 pts
36Gy + 18 Gy to tumor bedRT
ANOCEF 1990 and November 2001, 46 pts
STANDARD RISK ADULTS
Courtesy Alba Brandes
Courtesy Luc Talliandier
5y PFS 10y EFS
52% 46%
![Page 35: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/35.jpg)
SCHÉMA DE TRAITEMENT
2 courses chemo
(Carbo AUC 5 D1
etoposide 100 mg/m2 d 1-3)
PROSPECTIVE ANOCEF RSMA
PI: Luc Taillandier
CT RT CT
Radiotherapy before day 80
24 Gy axis + 54 Gy tumor bed
2 courses of chemotherapy
2/3 dose
![Page 36: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/36.jpg)
Clinical ExperienceHigh RiskChildren
![Page 37: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/37.jpg)
High dose chemo: PNET HR +5
B
I
O
P
S
I
E
+/-
E
X
E
R
E
S
E
VP
CBP
HDThiotepa
HDThiotepa
E
X
E
R
E
S
E
R
A
D
I
O
T
H
E
R
A
P
Y
36Gy
CSP
VP
CBP
CSP
Cytapheresis
E
X
E
R
E
S
E
IRM IRMIRM
2 cyclesTMZ
2 cyclesTMZ
2 cyclesTMZ
IRM IRM IRM
64 patients (MB=51; sPNET=13) from 2009 to 2012, 3 year Follow-up
3-year PFS 80%, 3-year OS 85%
Dufour, SFCE
![Page 38: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/38.jpg)
Tarbell JCO 2013
INCREASING DOSE OF CSI
![Page 39: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/39.jpg)
Clinical ExperienceHigh Risk
Adults
![Page 40: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/40.jpg)
Bologna 1989 to 2009 95 pts
ANOCEF 1990 and November 2001, 46 pts
Courtesy Alba Brandes
Courtesy Luc Talliandier
CT RT CT
High RISK ADULTS
DEC Cisplatin 80 to 100 mg/m2-
Etoposide 100 to 200 mg/m2
Cyclophosphamide 600 to 1000 mg/m2
Or CBDCA AUC 5
Etoposide 300 mg/m2
Or MOPP
5y EFS 10y EFS
50% 36%
36Gy + 18 Gy to tumor bed
![Page 41: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/41.jpg)
Beware ofTOXICITY
![Page 42: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/42.jpg)
FEASIBILITY/TOXICITYCDDP/Lomustine/VCR
95 courses
Children
(5-10)
142 courses
Adolescents
(10-20)
p
Dose
Reduction24% 56% 0.02
Delayed
Chemo3% 23% 0.0003
Tabori Cancer, 2005, 1874
![Page 43: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/43.jpg)
Beier JNO 2018
Adaptations required
![Page 44: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/44.jpg)
IQ loss due to supra tentorial RT
>7
Year
<7
Year
Mulhern J Clin Oncol 2OO5, 23:5511-5519.
CSI 23 Gy CSI 36-39 Gy
(- 0.42
/year)
(- 2.41
/year,
P .05
(- 1.56
/year)
(- 3.71
/year,
P .01
![Page 45: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/45.jpg)
Fig 1 Modification of professional status according to the (from treatment) and CSA doses.
Loss of employment
SUNYACH Communication personnelle
< 30,6Gy
> 30,6Gy
![Page 46: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/46.jpg)
Delayed endocrinological toxicity in pediatric population
ACTH deficiency : 38+/-6%
TSH deficiency : 23+/-8% (11% if <42 Gy vs 44% if> 42 Gy: p
0.014)
GH Deficiency: 93+/-4%
Primary Thyroid deficiency : 65+/-7% (54% if <42 Gy vs 89% if> 42 Gy: p
0.017)
Laughton, JCO 2008, 1112
![Page 47: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/47.jpg)
Hypothyroidism
Children Adults
Central TSH deficiency 0% 26%
Peripheral SCH 43% 0%
![Page 48: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/48.jpg)
Second malignancies?.
Broniscer Cancer 2004
![Page 49: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/49.jpg)
Relapses
![Page 50: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/50.jpg)
Smoll (SEER) cancer 2011
Long term differs?
![Page 51: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/51.jpg)
Anti SHH:
One impressive response in adult medulloblastoma
![Page 52: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/52.jpg)
Converging?
![Page 53: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/53.jpg)
R
Modified NOA-07* (see page 2)
SHH M0 (p53wt) (postpub.)
Modified NOA-07 ,with radiotherapy* dose reduction (CSI 23,4 Gy)
and LDE225 200 mg OD daily or with drug holidays
Stan
dar
d
arm
Exp
eri
me
nta
l ar
m
WNT M0 (18+)Modified NOA-07 ,with radiotherapy* dose reduction (CSI 23,4 Gy)
n=90
n=90
15%
60%
15% n=24
n=13
Group 4 M0 (18+)
Modified NOA-07 ,with radiotherapy* dose reduction (CSI 23,4 Gy)
WNT M0 (18+)SHH M0 (p53wt) (postpub.)Group 4 M0 (18+)
Inte
rme
dia
te-r
isk
pat
ien
ts
![Page 54: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/54.jpg)
GLIOMAS
![Page 55: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/55.jpg)
ADULT HIGH GRADE GLIOMAS
![Page 56: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/56.jpg)
Though different…..
![Page 57: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/57.jpg)
HERBY
![Page 58: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/58.jpg)
BEV, bevacizumab; CI, confidence interval; EFS, event-free survival; HR, hazard ratio; RT, radiotherapy; TMZ, temozolomide
Pediatric High grade gliomas
EFS rates (central review; secondary endpoints)
RT/TMZ (n=59) BEV + RT/TMZ (n=62)
6-month EFS rate (95% CI) 66% (53–77) 68% (55–79)
1-year EFS rate (95% CI) 48% (35–61) 38% (26–51)
8.2 months(95% CI 7.8–12.7)
11.8 months(95% CI 7.9–16.4)
Stratified HR 1.44 (95% CI 0.90–2.30) p=0.13 (log-rank test)
BEV + RT/TMZ (n=62)RT/TMZ (n=59)
Time (months)
0
100
0 6 12 18 24 30 36 42
20
40
60
80
Pro
ba
bilit
y o
f E
FS
(%
)
48
RT/TMZ
BEV + RT/TMZ
No. at risk
59 37 26 16 9 6 2 242 32 21 14 7 4 2 2
62 40 20 12 7 5 1 153 29 18 8 6 2 1 1
![Page 59: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/59.jpg)
BRAIN STEM GLIOMAS
![Page 60: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/60.jpg)
DIPG biopsies
Roujeau T, Machado G, Garnett MR, et al. Stereotactic biopsy of
diffuse pontine lesions in children. J Neurosurg. 2007
![Page 61: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/61.jpg)
DIPG biology
EGFR (amp): 40% DIPG
mTO
R
erlotinib dasatinib
everolimus
MET inhibitor, crizotinib
nimotuzumab
PTEN loss: 60% DIPG
![Page 62: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/62.jpg)
![Page 63: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/63.jpg)
GERM CELL TUMORS
![Page 64: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/64.jpg)
Pineal+/- supra sellar
![Page 65: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/65.jpg)
![Page 66: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/66.jpg)
GERMINOMAS
Calaminus Neurooncol 2013
![Page 67: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/67.jpg)
EFS Pts Prot. Germinomas
0 12 24 36 48 60 72 84mois
0
0,2
0,4
0,6
0,8
1p
option A (CSI)
option B (CT+focal)
0.85±0.06
0.93±0.04
(CR 109/113)
(CR 45/51)
p=0.03
**
*
![Page 68: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/68.jpg)
Cumulative Recruitement
![Page 69: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/69.jpg)
Age French patients GCTII
0
2
4
6
8
10
12
14
<14 14-18 19-25 >26
![Page 70: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/70.jpg)
Converging?
![Page 71: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/71.jpg)
WEB CONFERENCE AYAEach Monday….
![Page 72: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/72.jpg)
2016185 presentations
0
20
40
60
80
100
120
MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS
![Page 73: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/73.jpg)
185 presentations of 145 patients
0
10
20
30
40
50
60
70
1ere intention 2 ieme intention 1ere=> puis à la rechute
1 fois
2fois
3fois
4fois
1rst Line 2nd Line 1rst => Further Line
once
Twice
Three T
Four T
![Page 74: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/74.jpg)
Ages
0
2
4
6
8
10
12
14
20-30 Yr 30-40 Yr > 40 Yr
![Page 75: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/75.jpg)
Age of patientsaccording to type of tumor
Mean Median Younguest Oldest
Medulloblastoma 31 29 16 64
Germ cell Tumor 23 22 7 47
Ependymoma 35 30 4 75
Pineal 43 19 18 87
PNET 37 29 17 73
Low grade Glioma 30 26 17 55
High Grade Glioma 27 22 15 60
Else 30 24 9 57
Inot documented 34 29 10 62
![Page 76: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/76.jpg)
SPECIALISTS
0
2
4
6
8
10
12
14
16 CHIR
ONCO
PED
ANAPATH
NEURO ONCO
ONCO
RT
![Page 77: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/77.jpg)
CONCLUSIONS
![Page 78: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/78.jpg)
Inclusion ages
Fern 2014 Lancet Oncol
TGM SIOP GCTII (any age)
BIOMEDE (- months-25 Year)
PersoMed (Pubertal Bone age-…….
![Page 79: Neuro-oncology in AYAs Joint efforts are worthwhile…… · MEDULLO ET PNET GLIOMES TGM EPENDYMOMES PINEALE NF1 MOELLE TRONCS. 185 presentations of 145 patients 0 10 20 30 40 50](https://reader031.vdocuments.net/reader031/viewer/2022031420/5c6b9b6209d3f216708bbe06/html5/thumbnails/79.jpg)
A multidiciplinary team
• A Pathologist up to date• A Molecular biologist • A surgeon used to « travel » in the PF• A radiotherapist used to CSI• An oncologists used to toxicities• An endocrinologist• A Quos specialist• A neurologist• Pediatric with adult multidisciplinary discussion
? Dedicated Units???Long term Follow-up of chronic sequelae..